Skip to main content

Month: August 2022

Teleflex to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

WAYNE, Pa., Aug. 31, 2022 (GLOBE NEWSWIRE) — Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 20th Annual Global Healthcare Conference at the Sheraton New York, on Wednesday, September 14, 2022 at 10:00 a.m. (ET). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency...

Continue reading

eGain Solve™ Conference Ushers the Renaissance of Knowledge to Empower Agents and Serve Customers

SUNNYVALE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — eGain Corporation (NASDAQ: EGAN), the leading knowledge management platform provider for customer engagement automation, announced eGain Solve™ 22 conference, showcasing the power of modern knowledge management to reimagine not only customer experiences but also agent desktop experiences in the digital-first, remote-first era. Free to attend, the conference will be held at the MGM Grand in Las Vegas, Nevada on October 11 and 12, 2022. “Knowledge is an underemphasized aspect of experience design and demands a higher prioritization. Gartner analysts have previously cited knowledge management (KM) as the No. 1 technology for enhancing the three main customer service perspectives of operational performance, CX and employee experience,” wrote Jim Davies of Gartner® in a recent research...

Continue reading

Asensus Surgical Announces Installation of Senhance Surgical System at Evangelical Hospital Goettingen-Weende

Evangelical Hospital Goettingen-Weende to become 7th Senhance Hospital in GermanySenhance Surgical System The Senhance Surgical System’s open-platform architecture allows for seamless integration of surgeon preference tools, including the 3DHD visualization system.RESEARCH TRIANGLE PARK, N.C., Aug. 31, 2022 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the installation of a Senhance® Surgical System in the General Surgery Department of Evangelical Hospital Goettingen-Weende of Göttingen, Germany. This agreement to lease and utilize a Senhance® Surgical System was one of two announced by the Company on August 8, 2022. “Goettingen-Weende has a significant...

Continue reading

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

In predictive animal models, BMB-101 demonstrated significant reduction in both the number and intensity of epileptic seizures VANCOUVER, British Columbia, Aug. 31, 2022 (GLOBE NEWSWIRE) — Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that it has dosed the first patient in a Phase I trial (NCT 05397041) for its lead product, BMB-101, for the treatment of Dravet Syndrome and other medical indications. The Phase I trial is being conducted in Adelaide, Australia, by CMAX Clinical Research, a clinical trial center specializing in a range of early-phase trials and first-time in-human studies. BMB-101, a next-generation, 5-HT2C selective...

Continue reading

Form 8.3 – [Diurnal Group plc – 30 08 2022 – Opening Declaration] – (HHL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: HARGREAVE HALE LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree DIURNAL GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – [EMIS Group plc – 30 08 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Admiral Markets AS 2022 Unaudited 6 Months Financial Results 

Admirals‘ results are exceptional  Compared to the same period last year, Admirals has significantly increased its net trading income, trading volumes and net profit in the first half of the year, continuing large-scale investments in IT and innovation. The company acquired new licenses in South Africa and Canada. These are  eloquent success stories of implementing a strong strategy with a long-term goal of ensuring financial freedom for 10 million people by 2030. Admirals Group AS net income increased by 143% (43 million euros versus 17.3 million euros in the same period of 2021) Net profit 24.01 million euros (-1.7 million euros in the same period of 2021)  “Despite the great uncertainty in the world economy and political situation, we continued to implement our long-term goals, continuing to unite personal finance and...

Continue reading

Burning Rock Reports Second Quarter 2022 Financial Results

GUANGZHOU, China, Aug. 31, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2022. Recent Business UpdatesTherapy Selection and Minimal Residual Disease (MRD)In-hospital and MRD driving growth uplift, but patient volumes negatively impacted by Covid related restrictions.For the in-hospital channel, we experienced severe Covid related impact in Shanghai and to a lesser extent in Beijing. However, other regions combined grew over 60% year-over-year in the second quarter of 2022 in terms of testing volume; For the central-lab channel, new product sales contributed 7% of the central laboratory...

Continue reading

Correction to No. 8/2022 – Interim report H1 2022 – Interim report was missing in the first upload

Nasdaq Copenhagen                                                                                Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 31 August 2022 ANNOUNCEMENT no. 8/2022 INTERIM REPORT, H1 2022 The company have today published the Interim Report for H1 2022 (covering the period from 1 January 2022 to 30 June 2022). The Interim Report is attached to this company announcement and can be downloaded from the company’s website www.cemat.dk. The interim report was missing in the first upload. Please find it attached in this announcement. Cemat A/S Jaroslaw LipinskiCEO This announcement has been prepared in a Danish-language and an English-language version. In case of doubt, the Danish version prevails.AttachmentsAnnouncement no. 8 – 31.08.2022 – Interim report H1 2022Cemat...

Continue reading

Hywin Holdings Announces Unaudited Financial Results for the Second Half and Full Year of Fiscal 2022

Hywin Holdings FY2022 Earnings Source: Hywin HoldingsStable earnings growth backed by diversified revenue mix and strong client loyalty Entering the health management industry by acquiring well selected targetsSHANGHAI, China, Aug. 31, 2022 (GLOBE NEWSWIRE) — Hywin Holdings Ltd. (“Hywin” or the “Company”) (NASDAQ: HYW), a leading independent wealth management service provider in China, today announced its unaudited financial results for the second half and full year of fiscal 2022 ended June 30, 2022. Second Half of Fiscal Year 2022 HighlightsNumber of clients1 increased by 10.8% to 141,058 as of June 30, 2022 from 127,317 as of June 30, 2021. Number of active clients2 increased by 13.5% to 38,744 in the six months ended June 30, 2022 from 34,149 in the same period of 2021. Aggregate transaction value of wealth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.